333 related articles for article (PubMed ID: 18418600)
1. The association of anti-CCP antibodies with disease activity in rheumatoid arthritis.
Serdaroğlu M; Cakirbay H; Değer O; Cengiz S; Kul S
Rheumatol Int; 2008 Aug; 28(10):965-70. PubMed ID: 18418600
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
[TBL] [Abstract][Full Text] [Related]
3. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
Agrawal S; Misra R; Aggarwal A
Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
[TBL] [Abstract][Full Text] [Related]
5. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
[TBL] [Abstract][Full Text] [Related]
6. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.
Lee DM; Phillips R; Hagan EM; Chibnik LB; Costenbader KH; Schur PH
Ann Rheum Dis; 2009 Feb; 68(2):201-8. PubMed ID: 18390910
[TBL] [Abstract][Full Text] [Related]
7. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
[TBL] [Abstract][Full Text] [Related]
8. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
9. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
10. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome.
Quinn MA; Gough AK; Green MJ; Devlin J; Hensor EM; Greenstein A; Fraser A; Emery P
Rheumatology (Oxford); 2006 Apr; 45(4):478-80. PubMed ID: 16287917
[TBL] [Abstract][Full Text] [Related]
11. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
Xie QB; Yin G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
13. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
Forslind K; Ahlmén M; Eberhardt K; Hafström I; Svensson B;
Ann Rheum Dis; 2004 Sep; 63(9):1090-5. PubMed ID: 15308518
[TBL] [Abstract][Full Text] [Related]
14. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
[TBL] [Abstract][Full Text] [Related]
15. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
[TBL] [Abstract][Full Text] [Related]
16. Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide.
Furuya T; Hakoda M; Ichikawa N; Higami K; Nanke Y; Yago T; Kobashigawa T; Tokunaga K; Tsuchiya N; Kamatani N; Kotake S
Clin Exp Rheumatol; 2007; 25(2):219-24. PubMed ID: 17543145
[TBL] [Abstract][Full Text] [Related]
17. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients.
Sulaiman FN; Wong KK; Ahmad WAW; Ghazali WSW
Medicine (Baltimore); 2019 Mar; 98(12):e14945. PubMed ID: 30896663
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibodies--activity markers in rheumatoid arthritis.
Predeteanu D; Varzaru L; Balanescu A; Bojinca V; Opris D; Vlad V; Berghea F; Abobului M; Constantinescu C; Ionescu R
J Med Life; 2009; 2(1):36-41. PubMed ID: 20108489
[TBL] [Abstract][Full Text] [Related]
19. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
[TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
del Val del Amo N; Ibanez Bosch R; Fito Manteca C; Gutierrez Polo R; Loza Cortina E
Clin Exp Rheumatol; 2006; 24(3):281-6. PubMed ID: 16870095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]